carbamates has been researched along with tiotropium bromide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amari, G; Bassani, F; Battipaglia, L; Bergamaschi, M; Berti, F; Bolzoni, PT; Cacciani, F; Cenacchi, V; Civelli, M; Delcanale, M; Geppetti, PA; Harrison, S; Mannini, F; Pastore, F; Patacchini, R; Petrillo, P; Razzetti, R; Rizzi, A; Rossoni, G; Santoro, E; Scudellaro, R; Villetti, G; Volta, R; Zaniboni, M | 1 |
| Ambery, C; Bateman, ED; Kornmann, O; Norris, V | 1 |
| Hegde, SS; Jaw-Tsai, S; Ji, Y; Martin, WJ; McNamara, A; Obedencio, GP; Pulido-Rios, MT | 1 |
| Chen, Y; Hegde, SS; Hughes, AD; Jasper, JR; Lee, TW; Mammen, M; Martin, WJ; McNamara, A; Pulido-Rios, MT; Steinfeld, T | 1 |
| Barnes, CN; Crater, G; Dean, L; Donohue, JF; Haumann, B; Kerwin, E; Moran, EJ; Pendyala, S; Sethi, S | 1 |
| Barnes, CN; Bourdet, D; Crater, G; Donohue, JF; Feldman, G; Pendyala, S; Sethi, S | 1 |
3 trial(s) available for carbamates and tiotropium bromide
| Article | Year |
|---|---|
Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Carbamates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate; Scopolamine Derivatives; Time Factors; Tiotropium Bromide; Treatment Outcome | 2013 |
Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Benzamides; Bronchodilator Agents; Carbamates; Case-Control Studies; Cholinergic Antagonists; Disease Progression; Drug Therapy, Combination; Drug Tolerance; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Safety; Severity of Illness Index; Tiotropium Bromide; Vital Capacity | 2019 |
Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Benzamides; Bronchodilator Agents; Carbamates; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Tiotropium Bromide | 2019 |
3 other study(ies) available for carbamates and tiotropium bromide
| Article | Year |
|---|---|
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Topics: Acetylcholine; Aged; Anesthesia; Animals; Blood Pressure; Bronchi; Bronchial Spasm; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Carbachol; Carbamates; CHO Cells; Cricetinae; Cricetulus; Diamines; Guinea Pigs; Heart Atria; Heart Rate; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Muscarinic Antagonists; Myocardial Contraction; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Scopolamine Derivatives; Tiotropium Bromide; Trachea; Transfection; Ventricular Function, Left | 2010 |
In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
Topics: Acetylcholine; Administration, Inhalation; Animals; Benzamides; Bronchoconstriction; Bronchodilator Agents; Carbamates; Dogs; Dose-Response Relationship, Drug; Glycopyrrolate; Lung; Male; Methacholine Chloride; Muscarinic Antagonists; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Salivation; Scopolamine Derivatives; Tiotropium Bromide | 2013 |
Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
Topics: Adrenergic beta-2 Receptor Antagonists; Albuterol; Animals; Bronchodilator Agents; Carbamates; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Evaluation, Preclinical; Guinea Pigs; HEK293 Cells; Humans; Lung; Muscarinic Antagonists; Muscle Relaxation; Muscle, Smooth; Protein Binding; Quinolones; Receptors, Adrenergic, beta; Receptors, Muscarinic; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Tissue Distribution; Trachea | 2014 |